Lorus Therapeutics' Virulizin shows better antitumor activity than Taxol in preclinical studies Jan. 10, 2001
Oxford BioMedica initiates phase I/II clinical trial of TroVax as treatment of colorectal cancer Jan. 8, 2001
RSS